Prostate Support *HEF

Quantità: 120 Caps (650mg per cap.)
Prezzo: 29.90€

Aggiungi al carrello

Opinioni dei Clienti (0)

Prostate Support è un coadiuvante della funzione della prostata, la cui formula è data dalla combinazione sinergica di 9 piante della foresta pluviale, note fra le tribù indigene per le loro proprietà antisettiche, antibatteriche, diuretiche e antimicotiche.
Il problema dell'ingrossamento della prostata colpisce circa il 96% degli uomini al di sopra dei 45 anni di età. L'ingrossamento della prostata può comportare oltre al problema di dover spesso urinare, specialmente di notte, impotenza e disfunzioni erettili. Fra le varie cause dell'ingrossamento della prostata, le più frequenti sono la riduzione del testosterone, infezioni o un tumore (che può essere sia benigno che maligno).

Che cosa significa "HEF"? Per scoprirlo, clicca qui.

Perchè acquistare Prostate Support? Per saperne di più clicca qui

Ingredienti: Miscela al 100% naturale di nettle, jatoba, mutamba, graviola, brazilian peppertree, vassourinha, cipó cabeludo, pau d'arco e anamu. Non sono stati aggiunti leganti o additivi.

Uso suggerito: Come integratore alimentare, assumere 2 capsule 2- 3 volte al giorno.

Indicazioni pratiche:

Test di laboratorio hanno dimostrato proprietà antimicrobiche di diverse piante contenute nel composto. Un uso prolungato può condurre alla diminuzione dei batteri benigni del tratto digestivo. Si consiglia di assumere probiotici o enzimi digestivi se si assume Prostate Support per più di 30 giorni.
Il cipó cabeludo contiene naturalmente cumarina che ha proprietà anticoagulanti. Si consiglia uno stretto monitoraggio agli individui che fanno uso di farmaci anticoagulanti o che soffrono di disturbi della coagulazione sanguigna come l'emofilia.
Alcuni studi hanno evidenziato proprietà ipotensive di alcune piante del composto. Si consiglia uno stretto monitoraggio agli individui che soffrono di bassa pressione arteriosa.

Chi ha acquistato Prostate Support ha richiesto anche:

Graviola, 100 capsule da 600mg di graviola (Annona muricata)
Anamu, pianta dell'Amazzonia che vanta una storia di utilizzo nella medicina popolare per le infezioni del tratto urinario
Huanarpo Macho, erba della foresta pluviale peruviana tradizionalmente usata per l'impotenza e come stimolante della libido
Male Plus, miscela di erbe della foresta pluviale usate come rimedi popolari contro l'impotenza e come stimolanti della libido maschile

Bibliografia

Nettle Root (Urtica dioica)
Popa, G., et al. “Efficacy of a combined Sabal-urtica preparation in the symptomatic treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study.” MMW Fortschr. Med. 2005 Oct; 147 Suppl 3:103-8.
Lopatkin, N., et al. “Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms—a placebo-controlled, double-blind, multicenter trial.” World J. Urol. 2005 Jun; 23(2): 139-46.
Walther, C., et al. “Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation." MMW Fortschr Med. 2005 Oct; 147(40):52-3.
Popa, G., et al. “Benign prostate syndrome: urinary tract symptoms can be eased with phytotherapy.” MMW Fortschr. Med. 2005 Aug; 147(33-34):42.
Schneider, T., et al. “Stinging nettle root extract (Bazoton-uno) in long term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months” Urologe A. 2004 Mar;43(3):302-6.
Durak I, et al. “Aqueous extract of Urtica dioica makes significant inhibition on adenosine deaminase activity in prostate tissue from patients with prostate cancer.” Cancer Biol. Ther. 2004; 3(9): 855-7.
Carson, C., et al. “The role of dihydrotestosterone in benign prostatic hyperplasia.” Urology. 2003; 61(4 Suppl 1): 2-7.
Melo, E. A., et al. “Evaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo controlled trial.” Int. Braz. J. Urol. 2002 Sep-Oct; 28(5): 418-25.
Koch, E. “Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms.” Planta Med. 2001; 67: 489-500.
Sokeland, J. “Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.” B. J. U. Int. 2000; 86(4): 439-42.
Schottner, M., et al. “Lignans from the roots of Urtica dioica and their metabolites bind to human sex hormone binding globulin (SHBG).” Planta Med. 1997; 63(6): 529-32.
Lichius, J. J., et al. “The inhibiting effects of Urtica dioica root extracts on experimentally induced prostatic hyperplasia in the mouse.” Planta Med. 1997; 63(4): 307-10.
Hryb, D. J., et al. “The effect of extracts of the roots of the stinging nettle (Urtica dioica) on the interaction of SHBG with its receptor on human prostatic membranes.” Planta Med. 1995; 61(1): 31-2.
Koch E. and A. Biber. "Pharmacological effects of saw palmetto and urtica extracts for benign prostatic hyperplasia." Urologe 1994; 34(2): 90-95.
Krzeski, T., et al. “Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses.” Clin. Ther. 1993; 15(6): 1011-20.

Jatobá (Hymenaea courbaril)
Abdel-Kader, M., et al. “Isolation and absolute configuration of ent-Halimane diterpenoids from Hymenaea courbaril from the Suriname rain forest.” J. Nat. Prod. 2002; 65(1): 11-5.
Rahalison, L., et al. “Screening for antifungal activity of Panamanian plants.” Inst. J. Pharmacog. 1993; 31(1): 68–76.
Verpoorte, R., et al. “Medicinal plants of Surinam. IV. Antimicrobial activity of some medicinal plants.” J. Ethnopharmacol. 1987; 21(3): 315–18.
Arrhenius, S.P., et al. “Inhibitory effects of Hymenaea and Copaifera leaf resins on the leaf fungus, Pestalotia subcuticulari.” Biochem. Syst. Ecol. 1983; 11(4): 361–66.
Tincusi, B. M., et al. “Antimicrobial terpenoids from the oleoresin of the Peruvian medicinal plant Copaifera paupera.” Planta Med. 2002; 68(9): 808–12.
Caceres, A., et al. “Plants used in Guatemala for the treatment of dermatomucosal infections. 1: Screening of 38 plant extracts.” J. Ethnopharmacol. 1991; 33(3): 277–83.
Verpoorte, R., et al. “Medicinal plants of Surinam. IV. Antimicrobial activity of some medicinal plants.” J. Ethnopharmacol. 1987; 21(3): 315–18.

Mutamba (Guazuma ulmifolia)
Camporese, A., et al. “Screening of anti-bacterial activity of medicinal plants from Belize (Central America).” J. Ethnopharmacol. 2003 Jul; 87(1): 103-7.
Navarro, M. C., et al. “Antibacterial, antiprotozoal and antioxidant activity of five plants used in Izabal for infectious diseases.” Phytother. Res. 2003; 17(4): 325-9.
Caceres, A., et al. “Anti-gonorrhoeal activity of plants used in Guatemala for the treatment of sexually transmitted diseases.” J. Ethnopharmacol. 1995; 48(2): 85–88.
Caceres, A., et al. “Plants used in Guatemala for the treatment of gastrointestinal disorders. 3. Confirmation of activity against enterobacteria of 16 plants.” J. Ethnopharmacol. 1993; 38(1): 31–38.
Caceres, A., et al. “Plants used in Guatemala for the treatment of respiratory diseases. 2: Evaluation of activity of 16 plants against gram-positive bacteria.” J. Ethnopharmacol. 1993; 39(1): 77–82.
Heinrich, M., et al. “Parasitological and microbiological evaluation of Mixe Indian medicinal plants.” (Mexico) J. Ethnopharmacol. 1992; 36(1): 81–85.
Caceres, A., et al. “Plants used in Guatemala for the treatment of gastrointestinal disorders. 1. Screening of 84 plants against enterobacteria.” J. Ethnopharmacol. 1990; 30(1): 55–73.
Caceres, A., et al. “Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases.” J. Ethnopharmacol. 1987; 20(3): 223–37.

Graviola (Annona muricata)
Takahashi, J. A., et al. “Antibacterial activity of eight Brazilian Annonaceae plants.” Nat. Prod. Res. 2006; 20(1):21-6
Betancur-Galvis, L., et al. “Antitumor and antiviral activity of Colombian medicinal plant extracts.” Mem. Inst. Oswaldo Cruz 1999; 94(4): 531-35.
Antoun, M. D., et al. “Evaluation of the flora of Puerto Rico for in vitro cytotoxic and anti-HIV activities. Pharmaceutical Biol. 1999; 37(4): 277-280.
Sundarrao, K., et al. “Preliminary screening of antibacterial and antitumor activities of Papua New Guinean native medicinal plants.” Int. J. Pharmacog. 1993; 31(1): 3–6.
Misas, C. A. J., et al. “Contribution to the biological evaluation of Cuban plants. IV.” Rev. Cubana Med. Trop. 1979; 31(1): 29–35.
Yuan, S. S., et al. “Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase-3-related pathway.” Life Sci. 2003 May: 72(25): 2853-61.

Brazilian Peppertree (Schinus molle)
de Lima, M. R., et al. “Anti-bacterial activity of some Brazilian medicinal plants.” J. Ethnopharmacol. 2005 Dec 12;
Schmourlo, G., et al. “Screening of antifungal agents using ethanol precipitation and bioautography of medicinal and food plants.” J. Ethnopharmacol. 2005 Jan; 96(3): 563-8.
de Carvalho, M. C. “Evaluation of mutagenic activity in an extract of pepper tree stem bark (Schinus terebinthifolius Raddi).” Environ. Mol. Mutagen. 2003; 42(3): 185-91.
de Melo, Jr., E. J., et al. “Medicinal plants in the healing of dry socket in rats: Microbiological and microscopic analysis.” Phytomedicine. 2002; 9(2): 109–16.
Quiroga, E. N., et al. “Screening antifungal activities of selected medicinal plants.” J. Ethnopharmacol. 2001; 74(1): 89–96.
Martinez, M. J., et al. “Screening of some Cuban medicinal plants for antimicrobial activity.” J. Ethnopharmacol. 1996; 52(3): 171–74.
Cuella, M. J., et al. “Two fungal lanostane derivatives as phospholipase A2 inhibitors.” J. Nat. Prod. 1996; 59(10): 977–79.
Gundidza, M., et al. “Antimicrobial activity of essential oil from Schinus molle Linn.” Central African J. Med. 1993; 39(11): 231–34.
Dikshit, A. “Schinus molle: a new source of natural fungitoxicant.” Appl. Environ. Microbiol. 1986; 51(5): 1085–88.
El-Keltawi, N., et al. “Antimicrobial activity of some Egyptian aromatic plants.” Herba Pol. 1980; 26(4): 245–50.
Ross, S., et al. “Antimicrobial activity of some Egyptian aromatic plants.” Fitoterapia. 1980; 51: 201–5.

Vassourinha (Scoparia dulcis)
Kasperczyk, H., et al. “Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy.” Oncogene. 2005 Oct; 24(46): 6945-56.
Fulda, S., et al. “Sensitization for anticancer drug-induced apoptosis by betulinic acid.” Neoplasia. 2005; 7(2): 162-70.
Garg, A. K., et al. “Chemosensitization and radiosensitization of tumors by plant polyphenols.” Antioxid. Redox. Signal. 2005; 7(11-12): 1630-47.
Ahmed, M., et al. “Analgesic, diuretic, and anti-inflammatory principle from Scoparia dulcis.” Pharmazie. 2001; 56(8): 657–60.
Freire, S., et al. “Analgesic and anti-inflammatory properties of Scoparia dulcis L. extracts and glutinol in rodents.” Phytother. Res. 1993; 7: 408–14.
Freire, S., et al. “Analgesic activity of a triterpene isolated from Scoparia dulcis (vassourinha).” Mem. Inst. Oswaldo Cruz. 1991; 86 (Suppl. II): 149–51.
Ratnasooriya, W. D., et al. “Antioxidant activity of water extract of Scoparia dulcis.” Fitoterapia. 2005 Mar; 76(2): 220-2.
Babincova, M., et al. “Free radical scavenging activity of Scoparia dulcis extract.” J. Med. Food. 2001; 4(3): 179-181.
Arisawa, M. “Cell growth inhibition of KB cells by plant extracts.” Natural Med. 1994; 48(4): 338–47.
Nishino, H. “Antitumor-promoting activity of scopadulcic acid B, isolated from the medicinal plant Scoparia dulcis L." Oncology. 1993; 50(2): 100–3.

Cipó Cabeludo (Mikania hirsutissima)
Ohkoshi, E., et al. “ent-Kaurenoic acids from Mikania hirsutissima (Compositae).” Phytochemistry. 2004 Apr; 65(7): 885-90.
Wilkins, M., et al. “Characterization of the bactericidal activity of the natural diterpene kaurenoic acid.” Planta Med. 2002; 68(5): 452–54.
Davino, S. C., et al. “Antimicrobial activity of kaurenoic acid derivatives substituted on carbon-15.” Braz. J. Med. Biol. Res. 1989; 22(9): 1127–29.
de Souza, C. P., et al. “Chemoprophylaxis of schistosomiasis: molluscacidal activity of natural products—assays with adult snails and oviposition.” An. Acad. Bras. Cienc. 1984; 56(3): 333–38.
Suyenaga, E. S., et al. "Anti-inflammatory investigation of some species of Mikania." Phytother. Res. 2002; 16(6): 519-23.
Paiva, L. A., et al. “Anti-inflammatory effect of kaurenoic acid, a diterpene from Copaifera langsdorffi on acetic acid-induced colitis in rats.” Vascul. Pharmacol. 2002 Dec; 39(6): 303-7.

Pau d'arco (Tabebuia impetiginosa)
Lee, J. H., et al. “Down-regulation of cyclooxygenase-2 and telomerase activity by beta-lapachone in human prostate carcinoma cells.” Pharmacol. Res. 2005; 51(6): 553-60.
Choi, Y. H., et al. “Suppression of human prostate cancer cell growth by beta-Lapachone via down-regulation of PRB phosphorylation and induction of Cdk Inhibitor p21(WAF1/CIP1).” J. Biochem. Mol. Biol. 2003 Mar; 36(2): 223-9.
Balassiano, I. T., et al. “Demonstration of the lapachol as a potential drug for reducing cancer metastasis. Oncol. Rep. 2005; 13(2): 329-33.
Park, B. S., et al. “Selective growth-inhibiting effects of compounds identified in Tabebuia impetiginosa inner bark on human intestinal bacteria.” J. Agric. Food Chem. 2005 Feb; 23;53(4): 1152-7.
Park, B. S., et al. “Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori.” J. Ethnopharmacol. 2005 Dec;
Machado, T. B., et al. “In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus.” Int. J. Antimicrob. Agents. 2003; 21(3): 279-84.
Portillo, A., et al. “Antifungal activity of Paraguayan plants used in traditional medicine.” J. Ethnopharmacol. 2001; 76(1): 93–8.
Nagata, K., et al. “Antimicrobial activity of novel furanonaphthoquinone analogs.” Antimicrobial Agents Chemother. 1998; 42(3): 700–2.
Binutu, O. A., et al. “Antimicrobial potentials of some plant species of the Bignoniaceae family.” Afr. J. Med. Sci. 1994; 23(3): 269–73.
Giuraud, P., et al. “Comparison of antibacterial and antifungal activities of lapachol and b-lapachone.” Planta Med. 1994; 60: 373–74.
Anesini, C., et al. “Screening of plants used in Argentine folk medicine for antimicrobial activity.” J. Ethnopharmacol. 1993; 39(2): 119–28.

Anamu (Petiveria alliacea)
Gomes, P. B., et al. “Study of antinociceptive effect of isolated fractions from Petiveria alliacea L. (tipi) in mice.” Biol. Pharm. Bull. 2005; 28(1): 42-6.
Lopes-Martins, R. A., et al. “The anti-inflammatory and analgesic effects of a crude extract of Petiveria alliacea L. (Phytolaccaceae).” Phytomedicine. 2002; 9(3): 245-48.
Dunstan, C. A., et al. “Evaluation of some Samoan and Peruvian medicinal plants by prostaglandin biosynthesis and rat ear oedema assays.” J. Ethnopharmacol. 1997 Jun; 57(1): 35-56.
Kim, S., et al. “Antibacterial and antifungal activity of sulfur-containing compounds from Petiveria alliacea L.” J. Ethnopharmacol. 2005 Oct 13;
Kubec, R., et al. “The lachrymatory principle of Petiveria alliacea.” Phytochemistry. 2003 May; 63(1): 37-40.
Ruffa, M. J., et al. “Antiviral activity of Petiveria alliacea against the bovine diarrhea virus. Chemotherapy 2002; 48(3): 144-47.
Benevides, P. J., et al. “Antifungal polysulphides from Petiveria alliacea L.” Phytochemistry. 2001; 57(5): 743-7.
Jovicevic, L., et al. “In vitro antiproliferative activity of Petiveria alliacea L. on several tumor cell lines.” Pharmacol. Res. 1993; 27(1): 105-06.
Rossi, V., et al. “Antiproliferative effects of Petiveria alliacea on several tumor cell lines.” Pharmacol. Res. Suppl. 1990; 22(2): 434.

AVVERTENZA: Le informazioni fornite in queste pagine hanno solo scopo informativo e sono tratte da pubblicazioni internazionali. Le proprietà naturali delle erbe sono unicamente da riferire alle comuni utilizzazioni nella tradizione popolare ed erboristica. I nostri prodotti non si propongono di diagnosticare, trattare, curare o prevenire alcuna malattia. Non si intende fornire suggerimenti per diagnosi o trattamenti di malattie. In caso di necessità consultare un medico.